These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9783114)

  • 21. Aspirin-induced platelet inhibition in patients undergoing cardiac surgery.
    Zimmermann N; Kurt M; Winter J; Gams E; Wenzel F; Weber AA; Hohlfeld T
    Platelets; 2007 Nov; 18(7):528-34. PubMed ID: 17957569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 24. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
    Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
    J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelets possess functional TGF-beta receptors and Smad2 protein.
    Lev PR; Salim JP; Marta RF; Osorio MJ; Goette NP; Molinas FC
    Platelets; 2007 Feb; 18(1):35-42. PubMed ID: 17365852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptors and platelet function.
    Coughlin SR
    Thromb Haemost; 1999 Aug; 82(2):353-6. PubMed ID: 10605724
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of garlic on platelet biochemistry and physiology.
    Rahman K
    Mol Nutr Food Res; 2007 Nov; 51(11):1335-44. PubMed ID: 17966136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cangrelor attenuates coated-platelet formation.
    Norgard NB; Hann CL; Dale GL
    Clin Appl Thromb Hemost; 2009; 15(2):177-82. PubMed ID: 18796456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanisms of thrombocyte activation and possibilities of their pharmacological regulation].
    Razumov VB; Gutkin AB; Omel'ianovskiĭ VV
    Kardiologiia; 1988 May; 28(5):118-22. PubMed ID: 2842536
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antithrombogenic effect of urokinase bound to the collagen surface with bifunctional antibodies].
    Stepanova IP; Tsybul'skaia MV; Domogatskiĭ SP
    Biull Eksp Biol Med; 1994 May; 117(5):504-7. PubMed ID: 9296703
    [No Abstract]   [Full Text] [Related]  

  • 34. [The function of hormonal receptors in modern pharmacology].
    Zárate A
    Gac Med Mex; 1991; 127(4):313-4. PubMed ID: 1665129
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet dysfunction in intraparenchymal hemorrhage.
    Creutzfeldt CJ; Becker KJ; Longstreth WT; Tirschwell DL; Weinstein JR
    Stroke; 2009 Nov; 40(11):e645; author reply e646. PubMed ID: 19797180
    [No Abstract]   [Full Text] [Related]  

  • 36. [The pharmacological regulation of thrombocyte activity].
    Dukhanin AS; Gubaeva FR
    Eksp Klin Farmakol; 1998; 61(4):66-71. PubMed ID: 9783114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Blood platelets metabolic and activation processes and options for their inhibition].
    Pecka M; Malý J
    Vnitr Lek; 2009 Mar; 55(3):263-6. PubMed ID: 19378857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isomers of trans fatty acids modify the activity of platelet 12-P lipoxygenase and cyclooxygenase/thromboxane synthase.
    Stachowska E; Dołegowska B; Olszewska M; Gutowska I; Chlubek D
    Nutrition; 2004 Jun; 20(6):570-1. PubMed ID: 15165621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of the new Russian concentrate of n-3 polyunsaturated fatty acids epaden on thrombocyte functional activity in vitro].
    Kalugin SA; Petrukhina GN; Makarov VA; Gandel' VG
    Eksp Klin Farmakol; 2000; 63(1):45-50. PubMed ID: 10763110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.